What kind of a company is Actavis plc?
Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.
How much is the market capitalization of Actavis?
In November 2014, Actavis PLC announced its intention to acquire Allergan Inc, the manufacturer of Botox Completion of the deal would increase its market capitalization to $147 billion.
When did Actavis move to the New York Stock Exchange?
The company was initially listed on the NASDAQ under the ticker symbol WATS. The company moved to the New York Stock Exchange (NYSE) in 1997, and began trading under the symbol WPI. Actavis facility in Iceland 2000 to 2009
When is the expiration date for Actavis?
Investors in Actavis plc (NYSE: ACT) saw new options begin trading today, for the February 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a […]
Who are the largest holders of Actavis stock?
At Holdings Channel, we have reviewed 3,749 13F filings for the 06/30/2014 reporting period, and noticed that Actavis (NYSE: ACT) was held by 10 of the particular managers we have flagged as “titans” most widely followed by […] Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.
What is the current short interest in Actavis?
The most recent short interest data has been released by the NASDAQ for the 03/31/2015 settlement date, which shows a 19,096,152 share decrease in total short interest for Actavis plc (NYSE: ACT), to 7,177,672, a decrease of 72.68% since 03/13/2015. Total short interest is just one way to look at […]
